Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

98 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Safety of Switching From a Vitamin K Antagonist to a Non-Vitamin K Antagonist Oral Anticoagulant in Frail Older Patients With Atrial Fibrillation: Results of the FRAIL-AF Randomized Controlled Trial.
Joosten LPT, van Doorn S, van de Ven PM, Köhlen BTG, Nierman MC, Koek HL, Hemels MEW, Huisman MV, Kruip M, Faber LM, Wiersma NM, Buding WF, Fijnheer R, Adriaansen HJ, Roes KC, Hoes AW, Rutten FH, Geersing GJ. Joosten LPT, et al. Among authors: hemels mew. Circulation. 2024 Jan 23;149(4):279-289. doi: 10.1161/CIRCULATIONAHA.123.066485. Epub 2023 Aug 27. Circulation. 2024. PMID: 37634130 Free article. Clinical Trial.
Coronary artery spasm: a rare cause of syncope.
Hemels ME, Wiesfeld AC, van den Berg F, Zijlstra F, van Gelder IC. Hemels ME, et al. Neth Heart J. 2005 Jan;13(1):21-22. Neth Heart J. 2005. PMID: 25696408 Free PMC article. No abstract available.
Safety of switching from vitamin K antagonist to non-vitamin K antagonist oral anticoagulant in frail elderly with atrial fibrillation: rationale and design of the FRAIL-AF randomised controlled trial.
Joosten LPT, van Doorn S, Hoes AW, Nierman MC, Wiersma NM, Koek HL, Hemels MEW, Huisman MV, Roes KC, van den Bor RM, Buding WF, Rutten FH, Geersing GJ. Joosten LPT, et al. Among authors: hemels mew. BMJ Open. 2019 Dec 29;9(12):e032488. doi: 10.1136/bmjopen-2019-032488. BMJ Open. 2019. PMID: 31888928 Free PMC article.
Atrial fibrillation in chronic heart failure patients with reduced ejection fraction: The CHECK-HF registry.
Veenis JF, Brunner-La Rocca HP, Linssen GCM, Smeele FJJ, Wouters NTAE, Westendorp PHM, Rademaker PC, Hemels MEW, Rienstra M, Hoes AW, Brugts JJ; CHECK-HF investigators. Veenis JF, et al. Among authors: hemels mew. Int J Cardiol. 2020 Jun 1;308:60-66. doi: 10.1016/j.ijcard.2020.03.001. Epub 2020 Mar 5. Int J Cardiol. 2020. PMID: 32173129 Free article.
Design and rationale of DUTCH-AF: a prospective nationwide registry programme and observational study on long-term oral antithrombotic treatment in patients with atrial fibrillation.
Chu G, Seelig J, Trinks-Roerdink EM, van Alem AP, Alings M, van den Bemt B, Boersma LV, Brouwer MA, Cannegieter SC, Ten Cate H, Kirchhof CJ, Crijns HJ, van Dijk EJ, Elvan A, van Gelder IC, de Groot JR, den Hartog FR, de Jong JS, de Jong S, Klok FA, Lenderink T, Luermans JG, Meeder JG, Pisters R, Polak P, Rienstra M, Smeets F, Tahapary GJ, Theunissen L, Tieleman RG, Trines SA, van der Voort P, Geersing GJ, Rutten FH, Hemels ME, Huisman MV. Chu G, et al. BMJ Open. 2020 Aug 24;10(8):e036220. doi: 10.1136/bmjopen-2019-036220. BMJ Open. 2020. PMID: 32843516 Free PMC article.
Impact of different anticoagulation management strategies on outcomes in atrial fibrillation: Dutch and Belgian results from the GARFIELD-AF registry.
Seelig J, Hemels MEW, Xhaët O, Bongaerts MCM, de Wolf A, Groenemeijer BE, Heyse A, Hoogslag P, Voet J, Herrman JR, Vervoort G, Hermans W, Wollaert B, Boersma LVA, Hermans K, Lucassen A, Verstraete S, Adriaansen HJ, Mairesse GH, Terpstra WF, Faes D, Pieterse M, Virdone S, Verheugt FWA, Cools F, Ten Cate H; GARFIELD-AF investigators. Seelig J, et al. Among authors: hemels mew. J Thromb Haemost. 2020 Dec;18(12):3280-3288. doi: 10.1111/jth.15081. Epub 2020 Sep 25. J Thromb Haemost. 2020. PMID: 32886853 Free PMC article.
98 results